688488 艾迪药业
已收盘 07-18 15:00:00
资讯
新帖
简况
艾迪药业07月18日主力资金流入343万元 连续3日加仓
自选股智能写手 · 07-18 15:19
艾迪药业07月18日主力资金流入343万元 连续3日加仓
艾迪药业:7月16日高管张杰增持股份合计5000股
证券之星 · 07-17 20:01
艾迪药业:7月16日高管张杰增持股份合计5000股
艾迪药业07月17日获主力加仓510万元 环比增加493.02%
自选股智能写手 · 07-17 15:19
艾迪药业07月17日获主力加仓510万元 环比增加493.02%
艾迪药业大幅上涨 获北向资金减持7.27万股
智选洞察 · 07-17 14:48
艾迪药业大幅上涨 获北向资金减持7.27万股
抗艾天使!艾迪药业五项临床研究报告入选美国 IDWeek 2024
艾迪药业 · 07-17 10:02
抗艾天使!艾迪药业五项临床研究报告入选美国 IDWeek 2024
艾迪药业:7月12日至7月15日高管傅和亮、张杰增持股份合计11.04万股
证券之星 · 07-16 20:01
艾迪药业:7月12日至7月15日高管傅和亮、张杰增持股份合计11.04万股
艾迪药业大跌5% 北向资金减持11.82万股
智选洞察 · 07-15
艾迪药业大跌5% 北向资金减持11.82万股
独家药品概念盘中拉升,艾迪药业涨4.76%
自选股智能写手 · 07-12
独家药品概念盘中拉升,艾迪药业涨4.76%
艾迪药业:7月10日高管傅和亮、张杰增持股份合计11.01万股
证券之星 · 07-11
艾迪药业:7月10日高管傅和亮、张杰增持股份合计11.01万股
艾迪药业(688488.SH)董事长及总裁累计增持44.60万股
智通财经 · 07-10
艾迪药业(688488.SH)董事长及总裁累计增持44.60万股
艾迪药业大幅上涨 获北向资金增持9.15万股
智选洞察 · 07-10
艾迪药业大幅上涨 获北向资金增持9.15万股
艾迪药业(688488.SH)董事、核心技术人员傅和亮增持69471.0股,增持金额67.87万元
面包财经 · 07-10
艾迪药业(688488.SH)董事、核心技术人员傅和亮增持69471.0股,增持金额67.87万元
概念掘金 | 创新药重磅政策落地!多主线投资机会显现
格隆汇 · 07-08
概念掘金 | 创新药重磅政策落地!多主线投资机会显现
艾迪药业大跌5.04% 北向资金增持32.45万股
智选洞察 · 07-08
艾迪药业大跌5.04% 北向资金增持32.45万股
7月5日艾迪药业涨10.60%,中庚小盘价值股票基金重仓该股
证券之星 · 07-05
7月5日艾迪药业涨10.60%,中庚小盘价值股票基金重仓该股
艾迪药业涨10.60%,首创证券一个月前给出“买入”评级
证券之星 · 07-05
艾迪药业涨10.60%,首创证券一个月前给出“买入”评级
生物制品行业盘中拉升,艾迪药业涨8.09%
自选股智能写手 · 07-05
生物制品行业盘中拉升,艾迪药业涨8.09%
独家药品概念盘中拉升,艾迪药业涨7.65%
自选股智能写手 · 07-05
独家药品概念盘中拉升,艾迪药业涨7.65%
艾迪药业:7月4日高管傅和亮增持股份合计14.64万股
证券之星 · 07-04
艾迪药业:7月4日高管傅和亮增持股份合计14.64万股
艾迪药业(688488.SH)实控人之一傅和亮及总裁张杰拟合计斥500万元至1000万元增持股份
智通财经 · 07-03
艾迪药业(688488.SH)实控人之一傅和亮及总裁张杰拟合计斥500万元至1000万元增持股份
公司概况
公司名称:
江苏艾迪药业股份有限公司
所属行业:
其他制造业
上市日期:
2020-07-20
主营业务:
江苏艾迪药业股份有限公司主营业务以为HIV为主的抗病毒业务及人源蛋白业务。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司荣获“2023年度扬州民营企业创新20强”、荣登“2022年度扬州市创新型企业50强”名单及“2022年度中国小分子药物企业创新力TOP30排行榜”。
发行价格:
13.99
{"stockData":{"symbol":"688488","market":"SH","secType":"STK","nameCN":"艾迪药业","latestPrice":9.78,"timestamp":1721286000000,"preClose":9.96,"halted":0,"volume":2787070,"delay":0,"floatShares":421000000,"shares":421000000,"eps":-0.2143,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.18,"latestTime":"07-18 15:00:00","open":9.83,"high":9.88,"low":9.58,"amount":27173000,"amplitude":0.0301,"askPrice":9.79,"askSize":47,"bidPrice":9.78,"bidSize":19,"shortable":0,"etf":0,"ttmEps":-0.2143,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721352600000},"adr":0,"adjPreClose":9.96,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721266200000,1721273400000],[1721278800000,1721286000000]],"highLimit":10.96,"lowLimit":8.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":420782808,"pbRate":3.69,"roa":"--","roe":"--","epsLYR":-0.18,"committee":-0.666667,"marketValue":4115000000,"floatMarketCap":4115000000,"peRate":-45.636956,"changeRate":-0.0181,"turnoverRate":0.0066,"status":1,"afterMarket":{"amount":0,"volume":0,"close":9.78,"buyVolume":0,"sellVolume":0,"time":1721288039754,"indexStatus":"已收盘 07-18 15:30:00","preClose":9.96}},"requestUrl":"/m/hq/s/688488/wiki","defaultTab":"wiki","newsList":[{"id":"2452817576","title":"艾迪药业07月18日主力资金流入343万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2452817576","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452817576?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:19","pubTimestamp":1721287197,"startTime":"0","endTime":"0","summary":"07月18日, 艾迪药业股价跌1.81%,报收9.78元,成交金额2717万元,换手率0.66%,振幅3.01%,量比0.74。艾迪药业今日主力资金净流入343万元,连续3日净流入,上一交易日主力净流入510万元,今日环比减少32.75%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为56.25%,平均涨幅为2.49%。该股近5个交易日下跌2.98%,主力资金累计净流入723万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出6622万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181540289f62a32a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181540289f62a32a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2452553241","title":"艾迪药业:7月16日高管张杰增持股份合计5000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452553241","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452553241?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:01","pubTimestamp":1721217690,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月17日市场公开信息、上市公司公告及交易所披露数据整理,艾迪药业最新董监高及相关人员股份变动情况:2024年7月16日公司董事,高级管理人员张杰共增持公司股份5000.0股,占公司总股本为0.0012%。艾迪药业近半年内的董监高及核心技术人员增减持详情如下:艾迪药业的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入18.22万,融资余额增加;融券净流入0.0,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700041051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2452189434","title":"艾迪药业07月17日获主力加仓510万元 环比增加493.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452189434","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452189434?lang=zh_cn&edition=full","pubTime":"2024-07-17 15:19","pubTimestamp":1721200790,"startTime":"0","endTime":"0","summary":"07月17日, 艾迪药业股价涨4.08%,报收9.96元,成交金额3687万元,换手率0.90%,振幅6.79%,量比0.94。艾迪药业今日主力资金净流入510万元,上一交易日主力净流入86万元,今日环比增加493.02%。|07月17日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|英可瑞|3.94%|#|上海凯鑫|3.40%|#|智微智能|3.18%|#|清源股份|1.99%|#|紫天科技|1.93%|#|我爱我家|1.91%|#|上海物贸|1.80%|#|莱绅通灵|1.74%|#|大连友谊|1.51%|#|北自科技|1.44%|艾迪药业所在的生物制品行业,今日主力净流入6649万元,行业排名12/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171537319f5bda8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171537319f5bda8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2452183929","title":"艾迪药业大幅上涨 获北向资金减持7.27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452183929","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452183929?lang=zh_cn&edition=full","pubTime":"2024-07-17 14:48","pubTimestamp":1721198900,"startTime":"0","endTime":"0","summary":"07月17日,艾迪药业股价大幅上涨,截至14点48分,艾迪药业上涨5.02%,报10.05元/股,突破10元整数关口,成交3463万元,换手率0.85%。资金动向截止发稿,艾迪药业获得主力净流入485万元,其中超大单流入172万元,大单流入312万元。北向资金方面,艾迪药业07月16日获得北向资金减持7.27万股,截至07月16日,北向资金当前共持有艾迪药业87.90万股,市值883万元,持股占流通股比为0.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717145009af92b653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717145009af92b653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2452972865","title":"抗艾天使!艾迪药业五项临床研究报告入选美国 IDWeek 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2452972865","media":"艾迪药业","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452972865?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:02","pubTimestamp":1721181779,"startTime":"0","endTime":"0","summary":"艾迪药业将在2024年美国感染性疾病学会周报告艾诺韦林和艾诺米替系列临床研究成果。艾诺韦林于2021年6月获批上市,是中国自主研发的首个抗艾口服新药。这五篇报告已被大会全部接受,获得了大会组委会和科学委员会的高度认可。此次艾诺韦林和艾诺米替的系列研究获得美国学术界的认可,同时美国FDA IND申报计划也获得了监管机构的积极反馈,这对于艾迪药业的经营发展,特别是海外市场的拓展具有重要的意义。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171019019f5a515f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171019019f5a515f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2451957299","title":"艾迪药业:7月12日至7月15日高管傅和亮、张杰增持股份合计11.04万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451957299","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451957299?lang=zh_cn&edition=full","pubTime":"2024-07-16 20:01","pubTimestamp":1721131287,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月16日市场公开信息、上市公司公告及交易所披露数据整理,艾迪药业最新董监高及相关人员股份变动情况:2024年7月12日至2024年7月15日公司董事,核心技术人员傅和亮、董事,高级管理人员张杰共增持公司股份11.04万股,占公司总股本为0.0262%。变动期间公司股价下跌3.77%,7月15日当日收盘报9.7元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600040118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2451666046","title":"艾迪药业大跌5% 北向资金减持11.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451666046","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451666046?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:56","pubTimestamp":1721012214,"startTime":"0","endTime":"0","summary":"07月15日,艾迪药业股价大幅下跌,截至10点56分,艾迪药业下跌5.00%,报9.68元/股,成交1496万元,换手率0.36%。北向资金方面,艾迪药业07月12日获得北向资金减持11.82万股,截至07月12日,北向资金当前共持有艾迪药业86.28万股,市值835万元,持股占流通股比为0.20%。最新财报显示,今年一季报,艾迪药业实现营业收入9,289.40万元,同比减少17.52%,净利润为-1,360.69万元,同比减少2898.79%,基本每股收益为-0.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715105727aef9a87f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715105727aef9a87f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2450734202","title":"独家药品概念盘中拉升,艾迪药业涨4.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450734202","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450734202?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:53","pubTimestamp":1720749236,"startTime":"0","endTime":"0","summary":"07月12日,独家药品概念盘中拉升,截至09点53分,独家药品概念整体指数上涨1.00%,报780.000点。从个股上来看,该概念的成分股中,艾迪药业涨4.76%,新里程、舒泰神、XD珍宝岛涨幅居前。从资金上来看,截止发稿,独家药品概念概念主力净流入为-3147.25万,其中XD达仁堂受到资金热捧,主力净流入965.24万;拉长时间线来看,该板块近20日主力资金净流入-32.98亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095356941f6788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095356941f6788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2450359983","title":"艾迪药业:7月10日高管傅和亮、张杰增持股份合计11.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450359983","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450359983?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:01","pubTimestamp":1720699296,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月11日市场公开信息、上市公司公告及交易所披露数据整理,艾迪药业最新董监高及相关人员股份变动情况:2024年7月10日公司董事,核心技术人员傅和亮、董事,高级管理人员张杰共增持公司股份11.01万股,占公司总股本为0.0262%。艾迪药业近半年内的董监高及核心技术人员增减持详情如下:艾迪药业的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出316.36万,融资余额减少;融券净流入8569.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100038920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2450895102","title":"艾迪药业(688488.SH)董事长及总裁累计增持44.60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450895102","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450895102?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:44","pubTimestamp":1720611873,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾迪药业(688488.SH)发布公告,2024年7月10日,公司实际控制人之一、董事长傅和亮以及公司董事兼总裁张杰作为增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份44.60万股,占公司总股本的0.11%,合计增持金额为人民币423.52万元,已超过本次增持计划下限金额的一半,本次增持计划尚未实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2450874728","title":"艾迪药业大幅上涨 获北向资金增持9.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450874728","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450874728?lang=zh_cn&edition=full","pubTime":"2024-07-10 10:28","pubTimestamp":1720578495,"startTime":"0","endTime":"0","summary":"07月10日,艾迪药业股价大幅上涨,截至10点28分,艾迪药业上涨5.05%,报9.99元/股,成交2054万元,换手率0.50%,振幅6.20%。资金动向截止发稿,艾迪药业获得主力净流入241万元,其中超大单流入34万元,大单流入206万元。北向资金方面,艾迪药业07月09日获得北向资金增持9.15万股,截至07月09日,北向资金当前共持有艾迪药业107.01万股,市值1069万元,持股占流通股比为0.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710102832aef8dbf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710102832aef8dbf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2450881982","title":"艾迪药业(688488.SH)董事、核心技术人员傅和亮增持69471.0股,增持金额67.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450881982","media":"面包财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450881982?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:36","pubTimestamp":1720575360,"startTime":"0","endTime":"0","summary":"信披数据显示,2024年7月8日,艾迪药业(688488.SH)董事、核心技术人员傅和亮通过二级市场买卖增持6.95万股 ,成交均价为9.77元/股 ,增持金额为67.87万元,变动后持股数为231.7万股。面包财经梳理上交所披露数据显示,近半年来,公司董事、监事、高级管理人员、核心技术人员合计增持8次,合计增持99.39万股 ,合计增持 金额为1131.36万元。注:以上信息由上市公司自行向交易所填报。(文章序列号:1810819571800739840/JZY","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100937029f295944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100937029f295944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2449471187","title":"概念掘金 | 创新药重磅政策落地!多主线投资机会显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2449471187","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449471187?lang=zh_cn&edition=full","pubTime":"2024-07-08 11:03","pubTimestamp":1720407822,"startTime":"0","endTime":"0","summary":"前景向好","market":"hk","thumbnail":"https://img3.gelonghui.com/b2683-2091f5cb-365b-4f9a-b8c2-21c160148bbb.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/b2683-2091f5cb-365b-4f9a-b8c2-21c160148bbb.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/836139","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0070","BK0183","BK0201","600867","LU1328615791.USD","688506","BK0028","LU0405327494.USD","BK0185","BK0196","BK1161","BK0060","600276","LU1064130708.USD","BK0239","BK0262","LU0405327148.USD","BK0012","688488","06978","600521","BK1574","LU2148510915.USD","688180","BK0188","LU1064131003.USD"],"gpt_icon":0},{"id":"2449715348","title":"艾迪药业大跌5.04% 北向资金增持32.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449715348","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449715348?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:56","pubTimestamp":1720403761,"startTime":"0","endTime":"0","summary":"07月08日,艾迪药业股价大幅下跌,截至09点56分,艾迪药业下跌5.04%,报9.61元/股,成交2633万元,换手率0.63%,振幅8.20%。资金动向截止发稿,艾迪药业获得主力净流出264万元。北向资金方面,艾迪药业07月05日获得北向资金增持32.45万股,截至07月05日,北向资金当前共持有艾迪药业101.62万股,市值976万元,持股占流通股比为0.24%。最新财报显示,今年一季报,艾迪药业实现营业收入9,289.40万元,同比减少17.52%,净利润为-1,360.69万元,同比减少2898.79%,基本每股收益为-0.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708095638af90f11a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708095638af90f11a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2449425807","title":"7月5日艾迪药业涨10.60%,中庚小盘价值股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449425807","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449425807?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:16","pubTimestamp":1720167383,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日艾迪药业涨10.60%,收盘报10.12元,换手率2.07%,成交量8.71万手,成交额8515.46万元。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为中庚小盘价值股票。中庚小盘价值股票目前规模为44.49亿元,最新净值1.9475,较上一交易日下跌2.12%,近一年下跌17.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500029582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159990","399377","688488","BK0262"],"gpt_icon":0},{"id":"2449253888","title":"艾迪药业涨10.60%,首创证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2449253888","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449253888?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:16","pubTimestamp":1720167377,"startTime":"0","endTime":"0","summary":"今日艾迪药业涨10.60%,收盘报10.12元。2024年5月15日,首创证券研究员王斌发布了对艾迪药业的研报《公司简评报告:创新药销售持续改善,进入快速增长阶段》,该研报对艾迪药业给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为41.02%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为财通证券的华挺、张文录、邹一瑜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500029579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601136","688488"],"gpt_icon":0},{"id":"2449286172","title":"生物制品行业盘中拉升,艾迪药业涨8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449286172","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449286172?lang=zh_cn&edition=full","pubTime":"2024-07-05 10:41","pubTimestamp":1720147319,"startTime":"0","endTime":"0","summary":"07月05日,生物制品行业盘中拉升,截至10点41分,生物制品行业整体指数上涨1.05%,报5698.790点。从个股上来看,该行业的成分股中,艾迪药业涨8.09%,智翔金泰-U涨幅超过5%。从资金上来看,截止发稿,生物制品行业主力净流入为-7802.84万,其中天坛生物受到资金热捧,主力净流入745.25万;拉长时间线来看,该板块近20日主力资金净流入-32.63亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705104159941f41c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705104159941f41c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2449285904","title":"独家药品概念盘中拉升,艾迪药业涨7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449285904","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449285904?lang=zh_cn&edition=full","pubTime":"2024-07-05 10:41","pubTimestamp":1720147267,"startTime":"0","endTime":"0","summary":"07月05日,独家药品概念盘中拉升,截至10点41分,独家药品概念整体指数上涨1.01%,报757.600点。从个股上来看,该概念的成分股中,艾迪药业涨7.65%,君实生物-U、益佰制药、振东制药涨幅居前。从资金上来看,截止发稿,独家药品概念概念主力净流入为-7453.82万,其中华润三九受到资金热捧,主力净流入657.56万;拉长时间线来看,该板块近20日主力资金净流入-41.88亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070510410796819cfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070510410796819cfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2448442439","title":"艾迪药业:7月4日高管傅和亮增持股份合计14.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448442439","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448442439?lang=zh_cn&edition=full","pubTime":"2024-07-04 20:01","pubTimestamp":1720094488,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月4日市场公开信息、上市公司公告及交易所披露数据整理,艾迪药业最新董监高及相关人员股份变动情况:2024年7月4日公司董事,核心技术人员傅和亮共增持公司股份14.64万股,占公司总股本为0.0348%。艾迪药业近半年内的董监高及核心技术人员增减持详情如下:艾迪药业的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出428.33万,融资余额减少;融券净流出9300.0,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400039256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2448035101","title":"艾迪药业(688488.SH)实控人之一傅和亮及总裁张杰拟合计斥500万元至1000万元增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2448035101","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448035101?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:13","pubTimestamp":1720008838,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾迪药业(688488.SH)公告,公司实际控制人之一、董事长傅和亮以及公司董事兼总裁张杰拟自2024年7月4日起6个月内,通过上海证券交易所交易系统允许的方式(包括但不限于集中竞价和大宗交易)增持公司股份,二位合计增持金额不低于人民币500万元且不超过人民币1000万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688488","BK0262"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-20","address":"江苏省扬州市邗江区新甘泉西路69号","stockEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.2311},{"period":"3month","weight":-0.3175},{"period":"6month","weight":-0.2658},{"period":"1year","weight":-0.1583},{"period":"ytd","weight":-0.2182}],"companyName":"江苏艾迪药业股份有限公司","boardCode":"AI0041","perCapita":"51084股","boardName":"其他制造业","registeredCapital":"42078万元","compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":-0.0175},{"period":"3month","weight":-0.0288},{"period":"6month","weight":0.0511},{"period":"1year","weight":-0.0693},{"period":"ytd","weight":0.0007}],"survey":" 江苏艾迪药业股份有限公司主营业务以为HIV为主的抗病毒业务及人源蛋白业务。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司荣获“2023年度扬州民营企业创新20强”、荣登“2022年度扬州市创新型企业50强”名单及“2022年度中国小分子药物企业创新力TOP30排行榜”。","serverTime":1721338477361,"listedPrice":13.99,"stockholders":"8237人(较上一季度减少18.80%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾迪药业,688488,艾迪药业股票,艾迪药业股票老虎,艾迪药业股票老虎国际,艾迪药业行情,艾迪药业股票行情,艾迪药业股价,艾迪药业股市,艾迪药业股票价格,艾迪药业股票交易,艾迪药业股票购买,艾迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}